Skip to main content
Back
Watch Compare

Coeptis Therapeutics Holdings, Inc.

Data quality: 100%
Also listed as COEPW Nasdaq
COEP
Nasdaq Financial Services Nondepository Credit Institutions
$11.95
▼ $0.67 (-5.31%)
Mkt Cap: 78.16 M
Price
$12.56
Mkt Cap
78.16 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Debt/Equity of 0.01 — conservative balance sheet
Negative free cash flow of -8.60 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-144.79%
Below sector avg (9.24%)
ROIC-107.38%
Net Margin-874.29%
Op. Margin-956.94%

Safety

Debt / Equity
0.01
Below sector avg (0.49)
Current Ratio2.21
Interest Coverage-134.82

Valuation

PE (TTM)
-6.56
Below sector avg (11.15)
P/B Ratio7.54
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Financial Services sector median (2180 peers)
Metric Stock Sector Median
P/E -6.6 11.1
P/B 7.5 1.2
ROE % -144.8 9.2
Net Margin % -874.3 9.4
Rev Growth 5Y % — 5.8
D/E 0.0 0.5

Analyst Price Target

No analyst coverage available

Earnings Estimates

No forward estimates available

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q32024 -$1.00 -$1.08 -7.6%
Q22024 -$1.80 -$1.70 +5.8%
Q12024 N/A -$1.60 —
Q42023 -$3.20 -$1.33 +58.5%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1.36 M Net Income (TTM) -11.92 M
ROE -144.79% ROA -90.37%
Gross Margin 86.75% Operating Margin -956.94%
Net Margin -874.29% Free Cash Flow (TTM) -8.60 M
ROIC -107.38% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.01 Current Ratio 2.21
Interest Coverage -134.82 Asset Turnover 0.10
Working Capital 3.29 M Tangible Book Value 9.96 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -6.56 Forward P/E N/A
P/B Ratio 7.54 P/S Ratio 57.34
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -11.01%
Market Cap 78.16 M Enterprise Value 78.31 M
Per Share
EPS (Diluted TTM) -2.81 Revenue / Share 0.22
FCF / Share -1.38 OCF / Share -1.38
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 72.19%
SBC-Adj. FCF -8.70 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1.36 M 0.0 0.0 0.0 —
Net Income -11.92 M -10.88 M -21.27 M -37.57 M 15.23 M
EPS (Diluted) -2.81 -5.65 -0.83 -2.63 —
Gross Profit 1.18 M 0.0 0.0 0.0 —
Operating Income -13.04 M -10.05 M -21.49 M -34.20 M -681,319.0
EBITDA — — — — —
R&D Expenses 1.28 M 2.33 M 6.67 M 20,887.0 —
SG&A Expenses — — — — —
D&A 1.18 M 1.00 M 1.00 M 1.00 M —
Interest Expense 96,744.0 396,116.0 107,685.0 218,412.0 —
Income Tax 0.0 0.0 0.0 0.0 —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 16.15 M 8.91 M 8.07 M 7.92 M 76.17 M
Total Liabilities 2.09 M 5.04 M 3.76 M 3.11 M 7.19 M
Shareholders' Equity 13.56 M 3.19 M 4.31 M 4.80 M -6.77 M
Total Debt 150,000.0 — 1.13 M 150,000.0 —
Cash & Equivalents — — — — 404,345.0
Current Assets 7.35 M 1.05 M 5.25 M 3.94 M 412,678.0
Current Liabilities 1.77 M 4.51 M 2.99 M 1.82 M 139,927.0